High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190 PURPOSE: To characterize the pharmacokinetics of topotecan in a population model that ...
Mycophenolate mofetil (MMF, CellCept ®; Roche Laboratories, Nutley, NJ, USA) has been widely accepted as the antimetabolite immunosuppressant of choice in the immunosuppressive regimen of solid organ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback